Skriinimine
Skriinimine is the systematic process of evaluating individuals or populations to identify those at higher risk of a disease or to detect conditions or hazards at an early stage, typically before symptoms are present. It is distinct from diagnostic testing, which confirms a suspected disease in symptomatic individuals. Screening programs aim to reduce morbidity or mortality by enabling earlier intervention, but they rely on tests with adequate sensitivity and specificity and on effective follow-up care.
Key elements include the target population, an acceptable test, clear thresholds for positive results, pathways to
In health care, common examples are mammography for breast cancer, cervical cytology or HPV testing, colorectal
Limitations and debates surround screening: false positives and negatives, overdiagnosis, anxiety, exposure to unnecessary procedures, and